Why Sun Basket Is More Like Stitch Fix Than Blue Apron
The troubles Blue Apron's faced since going public last year has raised one big question for other meal-kit delivery start-ups in the ever-more-crowded space: what makes you stand out?
But Sun Basket's CEO doesn't think that question applies to his company.
“For us, it’s a fundamentally very different business,” Adam Zbar told Cheddar.
While Sun Basket does deliver packaged, pre-portioned meal-prep kits, it specializes on specific diets from Paleo to Mediterranean to gluten-free. Zbar says that gives his customers a more curated experience, more akin [Stitch Fix](https://cheddar.com/videos/how-stitch-fix-navigated-a-male-dominated-vc-landscape), the online styling subscription service.
Grocery shopping is harder for people sticking to strict diets than it is for those who don't have restrictions, explained Zbar. He says the convenience provided by Sun Basket makes it less likely customers abandon their subscriptions.
“Our retention rates are much higher than other players in the field, and the reason why is that we focused on a need.”
The company’s business model seems to resonate with investors too. Earlier this year, Sun Basket raised another [$57.8 million](https://www.prnewswire.com/news-releases/sun-basket-raises-578-million-in-new-funding-led-by-august-capital-300588291.html) in funding.
For full interview, [click here](https://cheddar.com/videos/healthy-cooking-made-easy).
Comcast announced that the company has beaten its projected earnings for Q4. However, the telecommunications giant fell short of its predictions for customer growth.
Kim Kardashian’s shapewear brand Skims has doubled its valuation to $3.2 billion. Investors have taken a bet on the success of this brand in the form of fresh funds for the two-year-old company.
McDonald's missed on both the top and bottom lines in its Q4 earnings, marking the fourth loss for the fast-food giant in the past eight quarters. It comes as higher costs from food to wages ate into the blue-chip company's profits. George Seay, CEO of investment advisor Annandale Capital, joined Wake Up with Cheddar to discuss the recent numbers and the better-than-expected success of the McPlant burger made with plant-based Beyond Meat. "They're changing with the times, and they have to," Seay noted. "You can just sell a Big Mac to everybody. There's a lot of people who don't want to eat a Big Mac anymore."
Moderna launched a clinical trial of a COVID-19 booster shot specifically targeting the omicron variant. The first participant has already received a dose, and Moderna expects to enroll about 600 adults total, split between two groups. In the first group, participants will have previously received two doses of the Moderna vaccine, and in the second, participants will have received its booster. Dr. Paul Burton, chief medical officer at Moderna, joined Cheddar’s Opening Bell to discuss the trial, yearly boosters, and what lies ahead for the company.
